Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma

Fig. 6

Association of NET1, KCNK1, MAL2, PLS1, and PLS3 expression with PDA prognosis, as determined with TCGA, R2, and ICGC data. A, C, E, G, and I Kaplan–Meier curves and log-rank test results for PDA patients from TCGA. B, D, F, H, and J Kaplan–Meier curves and log-rank test results for PDA patients from the R2 and ICGC. Both studies show that patients with high PLS3-expressing PDA had poorer overall survival. PDA pancreatic ductal adenocarcinoma, TCGA The Cancer Genome Atlas, R2 The R2 Genomics Analysis and Visualization Platform, ICGC International Cancer Genome Consortium

Back to article page